New Substituted Piperazines as Ligands for Melanocortin Receptors. Correlation to the X-ray Structure of “THIQ”
- 1 August 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (18) , 4613-4626
Abstract
A series of piperazine analogues of the melanocortin 4 receptor (MC4R) specific small-molecule agonist “THIQ” was synthesized and characterized structurally and pharmacologically. First, several THIQ imitations lacking the triazole moiety were prepared. Syntheses included acylation of 4-phenylpiperazine or 4-cyclohexylpiperazine. In two cases the tertiary amine function was replaced by the corresponding N-oxide. To obtain more complex structures, a 4-substituted piperazine ring was formed by alkylation of the primary amino group of cyclohexane-derived amino alcohols with N,N-bis(2-chloroethyl)benzylamine. The hydroxylic group of the intermediate was first activated with methanesulfonyl chloride, and the sulfonic ester formed in situ was introduced into the reaction with the sodium salt of 1,2,4-triazole. In one case (i.e., preparation of 23c) introduction of the 1,2,4-triazole moiety was performed at a carbon of the cyclohexane ring. In addition, this intermediate contained a piperazine moiety connected via its nitrogen atom to a cyclohexane ring carbon neighboring the reaction center. As established in NMR and X-ray investigations herein, this substitution proceeded with retention of the initial trans configuration of 1,2-disubstituted cyclohexane. To obtain pure enantiomers of 23c, its precursor 21c was subjected to chiral chromatography on a Chirobiotic V column. The derivatives (R,R)-21cand (S,S)-21c obtained were introduced into further syntheses steps, giving (R,R)-23c and (S,S)-23c, respectively. Melanocortin MC1,3-5 receptor binding studies showed that all tested piperazine derivatives were active. Several compounds showed clear selectivity for MC4R, with submicromolar affinities being obtained. Among them, one substance, (R,R)-23c, displayed a biphasic curve in displacement of [125I]NDP-MSH on MC4R [K(i)high = 1 nM and K(i)low = 260 nM]. This biphasic competition curve was similarly biphasic to the competition curve obtained herein using THIQ. An X-ray study performed on crystals of the THIQ sulfate salt revealed two closely related conformations, which resemble the shape of the letter “Y”, where piperidine and 4-chlorophenyl groups are situated close to each other, but the 1,2,3,4-tetrahydroisoquinoline residue is remote, the triazole function being highly exposed to the environment. The crystals of the dinitrate salt of (R,R)-23c showed a different conformation, where parts of the molecule are spread out almost symmetrically around the central section. Molecular modeling, based on the THIQ crystal structure and the functional similarity of THIQ and (R,R)-23c, allowed us to suggest a possible “bioactive” conformation of (R,R)-23c that is similar to the crystal conformation of THIQ.Keywords
This publication has 24 references indexed in Scilit:
- Novel selective melanocortin 4 receptor antagonist induces food intake after peripheral administrationBiochemical and Biophysical Research Communications, 2003
- Activation of melanocortin MC4 receptors increases erectile activity in rats ex copulaEuropean Journal of Pharmacology, 2002
- Recent advances in the development of melanocortin-4 receptor agonistsExpert Opinion on Therapeutic Patents, 2002
- The role of melanocortins in body weight regulation: opportunities for the treatment of obesityEuropean Journal of Pharmacology, 2002
- Selective, High Affinity Peptide Antagonists of α-Melanotropin Action at Human Melanocortin Receptor 4: Their Synthesis and Biological Evaluation in VitroJournal of Medicinal Chemistry, 2001
- Ligands to the melanocortin receptorsExpert Opinion on Therapeutic Patents, 2001
- Characterization of Melanocortin NDP-MSH Agonist Peptide Fragments at the Mouse Central and Peripheral Melanocortin ReceptorsJournal of Medicinal Chemistry, 2001
- The adrenocorticotropic hormone receptorCurrent Opinion in Endocrinology, Diabetes and Obesity, 2001
- New highly specific agonistic peptides for human melanocortin MC1 receptor☆Peptides, 2000
- Receptor Biology of the Melanocortins, a Family of Neuroimmunomodulatory PeptidesNeuroimmunomodulation, 1996